Fragment Separation
Optimising MLPA Fragment Separation
This document explains how to optimise MLPA signal intensities on your sequencer, an essential step in MLPA. It also specifies how much MLPA PCR reaction and which fluorescent primer label should be used in various capillary and non-capillary electrophoresis systems.
New Products
P484-ALPL
Hypophosphatasia (HPP)
Improved Products
P278-PCCA-PCCB
Propionic acidemia
P158-JPS
Juvenile polyposis syndrome (JPS)
P072-MSH6-MUTYH
Lynch syndrome; MUTYH-associated polyposis (MAP)
P225-PTEN
PTEN hamartoma tumor syndrome, Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, PTEN-related proteus syndrome, Proteus-like syndrome; (Tumour analysis for research use only)
P128-CYP450
Cytochrome P450
P021-SMA
Spinal muscular atrophy (SMA)
P409-RASA1-EPHB4
capillary malformations, Parkes Weber syndrome
P419-CDKN2A/2B-CDK4
Familial melanoma
P389-MLL2
Kabuki syndrome
P324-22q11
22q11
P202-IKZF1-ERG
Acute lymphoplastic leukemia (ALL), CVID, CML
Newsletter  |  Home  |  Privacy Policy  |  Terms and Conditions  |  Search  |  Sitemap  |  Copyright © 2019 MRC-Holland